292
Participants
Start Date
June 10, 2022
Primary Completion Date
September 30, 2025
Study Completion Date
March 31, 2029
MOTIV Sirolimus-Eluting Bioresorbable Scaffold
Participants will receive the MOTIV device
Percutaneous Transluminal Angioplasty (PTA) Device
Participants will receive PTA treatment
RECRUITING
UnityPoint Health Trinity Bettendorf Hospital, Bettendorf
RECRUITING
Cardiovascular Medicine PC, Davenport
RECRUITING
Adventist Health, St. Helena
RECRUITING
University Leipzig, Leipzig
REVA Medical, Inc.
INDUSTRY